Loading...
•
Dec 31, 2020
CareDx Q4 2020 Earnings Report
CareDx reported an increase in revenue and a decrease in net loss compared to the same quarter last year.
Key Takeaways
CareDx reported a strong fourth quarter, with a 64% increase in revenue compared to the prior year. The company also achieved record full-year revenue growth and made progress in expanding its services and solutions for transplant patients.
Total revenue reached $58.6 million, a 64% increase year-over-year.
Full year revenue was a record $192.2 million, up 51% compared to 2019.
Over 25,000 patient results were delivered in the fourth quarter.
GAAP net loss was $3.5 million, while non-GAAP net income was $4.3 million, and adjusted EBITDA was $4.9 million.
Revenue by Segment
Forward Guidance
CareDx expects revenue to be in the range of $255 million to $265 million for the full year 2021.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...